Treatment of Heart Failure Part 2 (Johnston) Flashcards
Five basic principles of Heart Failure
- Make correct diagnosis-exclude mimics of HF
- Determine etiology of heart disease
- Determine precipitating factors
- Understand pathophysiology of HF
- Understand mechanism of action (MOA) of pharmacological therapy
Indications for admission to Hospital for Management of Heart Failure
- Acute myocardial ischemia
- Severe respiratory distress
- Hypoxia
- Hypotension
- Cardiogenic shock
- Anasarca–fluids accumulating everywhere
- Syncope
- Heart failure refractory to oral medications
Treatment of Heart Failure–non pharmacologic
- Quit smoking
- If overweight, decrease calorie intake, AHA diet, diet instructions by dietician to patient and spouse
- 2g Na diet
Other treatment for heart failure
- Fluid restriction if Na is less than 126 (less than 2 L/day)
- Avoid isometric activity–increases SVR and after load
- Encourage isotonic activity–walking, hiking, golf
- Stool softener–bc don’t want them to strain
- Subcut Lovenox–anticoagulant to prevent blood clots in thighs and pelvic area
- Oxygen for 24 hours
- Avoid alcohol–depresses contractility in cardiac disease
- Treat hypertension, hyperlipidemia, diabetes
Treatment and counseling before discharge from hospital
- Diet: patient with spouse/other; sodium restriction, calorie restriction if overweight; stimulants (coffee, tea)
- Education
- Rehab, exercise
- Medications: ACE/ARB, Beta blocker, ASA, statin, Nitro prn
2nd ICS LSB diastolic murmur indicates what kind of valvular disease?
-Aortic regurgitation
Options for treatment for hypotension/syncope for someone who is taking ARB, beta blocker and lasix
-Hold diuretics and reduce dose of ARB and beta blocker
CO=
SV x HR
Stroke volume is modulated by
- Preload
- Afterload
- Contractility
Conventional treatment for acute heart failure
- Decrease Diuretics–reduce fluid volume
- Decrease Vasodilators–decrease preload and/or after load
- Increase Ionotropes–augment contractility
Classification of recommendation–Evidence based medicine–Class I
-Evidence and/or agreement that therapy is beneficial, useful and/or effective; benefit 3+ risk
Classification of recommendation–Evidence based medicine–Class II (IIa vs IIb)
- conflicting evidence and/or divergence of opinion
- IIa) Weight of evidence/opinion in favor–benefit 2+ risk
- IIb) Less established evidence/opinion–benefit 1+ risk
Classification of recommendation–Evidence based medicine class III
-Evidence and/or agreement that therapy/prodcedure is NOT effective; may be harmful–no benefit
Classification of recommendation level of evidence: A
-Data from meta-analysis or multiple randomized clinical trials; multiple populations evaluated
Classification of recommendation level of evidence: B
-Data from single randomized trial or non-randomized studies; limited population evaluated
-Data from single randomized trial or non-randomized studies; limited population evaluated: C
-Only consensus of opinion of experts, case studies, or standard of care, very limited populations evaluated
Pharmacological treatment of heart failure
- ACE inhibitors or ARB
- Beta blockers
- Diuretics
- Spironolactone
- Digitalis
- IV ionotropes
- Hydralazine
- Nitrates
- CCB
- Sacubitril–valsartan Ivabradine
ACE inhibitors
- Block conversion of ANg1 to Ang II
- Useful for ALL NYHA functional classifications with SYSTOLIC heart failure
- Lower mortality and morbidity by 20% supported by several good drug trials
- Useful in preventing HF in high risk patients (ASHD, MD, HT) level of evidence A
- Recommend in patients with symptoms of HF, reduced EF, unless contraindicated: L of E: A
Use ACEI cautiously when
-renal insufficiency is present (creatinine greater than 2.5mg) or potassium greater than 5
ACEI absolute contraindications
- Pregnancy!!
- Angioedema
- Bilateral RAS (renal artery stenosis)